Resources & Publications
Access valuable resources, research publications, policy briefs, and news from the pharmaceutical industry.
NAPharm History
Learn about the Nigeria Academy of Pharmacy since its inception.
2025 Calendar of Events
Official calendar of events and programs for the year 2025.
Academy Fellows Directory
Complete directory of all Fellows inducted since the Academy's founding.
NAPharm Executives Profile
Profiles of the current executive committee members of the Academy.
The Future of Pharmaceutical Manufacturing in Nigeria: 2026 and Beyond
An in-depth analysis of Nigeria's pharmaceutical manufacturing landscape, examining the impact of the Executive Order on Health Value Chains, the rise of API production, and the strategic roadmap to achieve 70% local production capacity by 2027.
Artificial Intelligence in Pharmacy Practice: Opportunities and Implementation Strategies for Nigerian Pharmacists
A comprehensive guide for Nigerian pharmacists on leveraging AI technologies—from drug discovery to patient care. Learn about AI-powered medication management, clinical decision support systems, and practical implementation strategies.
Understanding NAFDAC's 5+5 Directive and Ceiling List: A Pharmacist's Guide to Local Manufacturing Incentives
A detailed explanation of NAFDAC's regulatory framework designed to boost local pharmaceutical manufacturing. Learn how the 5+5 moratorium and Ceiling List are reshaping Nigeria's drug production landscape.
Malaria Vaccines in Nigeria: The RTS,S and R21 Rollout and Implications for Pharmacy Practice
A comprehensive analysis of the malaria vaccine rollout across Nigeria. Understand the differences between RTS,S and R21 vaccines, pharmacy's role in immunization programs, and the impact on malaria prevention strategies.
Career Pathways in Pharmaceutical Manufacturing: A Guide for Aspiring Industrial Pharmacists
Explore diverse career opportunities in Nigeria's growing pharmaceutical manufacturing sector. From production and quality assurance to regulatory affairs and R&D, discover how to build a successful career as an industrial pharmacist.
FDA Approves Multiple Breakthrough Therapies in February 2026
FDA granted approvals for Desmoda (diabetes insipidus), Yuviwel (achondroplasia), and Loargys (arginase deficiency). Dupixent became first approved therapy for allergic fungal rhinosinusitis in pediatric patients.
EMA Approves First Combined Flu-COVID mRNA Vaccine for Europe
CHMP recommended mCombriax as Europe's first combined influenza and COVID-19 mRNA vaccine for adults 50+. Uplizna approved for generalized myasthenia gravis with twice-yearly dosing.
AI in Healthcare Reaches Critical Mass: 70% of Organizations Now Using AI
FDA approvals for AI-enabled medical devices surpass 1,200. Agentic AI systems now handling complex pharmacy workflows, care coordination, and clinical decision support. AI scribes reducing physician burnout by 31%.
U.S. Signs Major PBM Reform: Rebates Must Be Passed Through to Medicare
President Trump signed the Consolidated Appropriations Act 2026. PBMs must now 'delink' compensation from drug rebates in Medicare Part D and pass through 100% of rebates to plan sponsors by January 2028.
Nigeria Targets 70% Local Drug Production by 2030: Royal Leaders Demand Action
At the 2026 NAIP Economic Outlook Forum, Emir of Kano and Obi of Onitsha called for acceleration toward 70% local production. Currently 70% of drugs are imported, with 82% from India.
Moderna Flu-COVID Combo Vaccine Nears Approval After Positive CHMP Opinion
Moderna's mRNA-1083 received positive CHMP opinion for combined influenza and COVID-19 protection. Company raised 2025 forecast to $1.9B revenue targeting 10% growth in 2026.
FDA Proposes New 'Plausible Mechanism Framework' for Ultra-Rare Disease Therapies
New regulatory pathway proposed for individualized genome editing and RNA-based therapies. Framework aims to accelerate access for ultra-rare diseases while maintaining safety standards.
57% of Pharma Companies Now Using AI Agents for Drug Discovery
NVIDIA survey reveals 57% of pharma/biotech companies use AI agents for drug discovery. Digital twins being deployed for tumor mapping and treatment planning. AI projected to generate $350-410B annually.
Herpes Vaccine Pipeline Advances: Multiple Candidates Show Promise in 2026
Assembly Bio's ABI-5366 shows potential for once-weekly/monthly dosing. Moderna's mRNA-1608 in Phase 1 trials. Pfizer/Valneva Lyme disease vaccine Phase 3 data expected this year.
Pharmacist Consultant Cadre Controversy Continues in Nigeria
Ongoing tension between Nigerian Medical Association and Pharmaceutical Society of Nigeria over implementation of consultant pharmacist positions at federal health institutions.
Digital Pharmacy Market to Reach $35.3 Billion by 2026
Global digital pharmacy market growing at 14.42% annually. Telepharmacy, e-prescriptions, and AI-powered medication management driving growth. Over 213 pharmaceutical jobs posted in Nigeria.
Takeda's Oveporexton Receives Priority FDA Review for Narcolepsy
First-in-class oral orexin receptor 2 agonist for narcolepsy type 1 accepted with priority review. PDUFA date expected Q3 2026. Phase 3 studies showed statistically significant improvement.
Baale Calls For Strategic Health Financing To Unlock Nigeria's Healthcare Value Chain
Prof. Lere Baale advocates for innovative financing models to transform Nigeria's healthcare sector and value chain.
Baale Calls For Innovative Pharmaceutical Research Manufacturing Ecosystem
Calls for a robust ecosystem to support pharmaceutical research and local manufacturing in Nigeria.
Pharmaceutical Drug Import Drops to 60%
NAFDAC DG reports a significant reduction in drug imports, signaling growth in local production capacity.
Innovation Key to Nigeria's Pharmaceutical Growth
NAPharm advocates for stronger research-policy collaboration to drive pharmaceutical growth.
Nigerian Academy of Pharmacy Inducts 14 New Fellows
A detailed report on the induction of 14 distinguished pharmacists into the Academy's fellowship.
Pharmacy Academy Inducts 14 New Fellows, Honours Six Others
Coverage of the prestigious induction ceremony and honors bestowed upon key industry figures.
Pharm. Yakasai Rallies Pharmacists to Drive National Development
Former PSN President Ahmed Yakasai charges pharmacists to lead innovation for national development.
Tribute to Late Pharm. Chief Oludolapo Ibukun Akinkugbe
The Academy pays tribute to its Founding President, Chief Olu Akinkugbe, celebrating his monumental legacy.
Omotosho, Ayebae, Osuide Bag NAPharm Lifetime Achievement Awards
Three industry giants honored with Lifetime Achievement Awards for their contributions to pharmacy.
NAPharm Reaffirms Leadership Role in Shaping Healthcare Future
The Academy restates its commitment to innovation and leadership in Nigeria's healthcare sector.
NAPharm Event Highlight (Video)
Highlights from the recent Nigerian Academy of Pharmacy events and inductions.